$ALBT News

Last published 3mo ago

3mo agoCHGA ALBTChange Agents Expands into Counter Drone Technologies with the Launch of Autonomous Air Defense LLC and Appointment of Major General Malcolm Frost to the Advisory BoardGlobeNewswireFREEHOLD, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Change Agents Corp. ("Change Agents" or the "Company") (NASDAQ:CHGA), a developer of agentic artificial intelligence ("AI") software solutions,
3mo agoALBT CHGAAvalon GloboCare Announces Strategic Transformation into Agentic AI Software Company; Rebrands as Change Agents Corp.GlobeNewswireCompany to begin trading tomorrow under new Nasdaq ticker symbol CHGA as it advances its portfolio of agentic AI software platforms, including Beacon and Catch-Up Company is actively evaluating additional AI software
3mo agoALBTAvalon GloboCare Expands AI Product Portfolio with Planned Launch of Beacon, an Agentic Generative Engine Optimization Platform for Small BusinessesGlobeNewswireFREEHOLD, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a technology innovation company developing products for high-growth health and
4mo agoALBTChief Patrick Flannelly Highlights KetoAir™ Progress in Supporting the Nevada First Responders Holistic Health Reset ProgramGlobeNewswireFREEHOLD, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a technology-innovation company with a strategic focus on developing innovative products and services
5mo agoALBTAvalon GloboCare Appoints Seasoned AI and Finance Executive as Chief Financial OfficerGlobeNewswireFREEHOLD, N.J., June 04, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a technology-innovation company with a strategic focus on developing innovative products and services
6mo agoALBTAvalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform DevelopmentGlobeNewswireFREEHOLD, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a technology-innovation company with a strategic focus on developing innovative products and services
7mo agoALBTAvalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video PlatformGlobeNewswireFREEHOLD, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a technology-innovation company with a strategic focus on developing innovative products and services
8mo agoALBTAvalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq RulesGlobeNewswireFREEHOLD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a diversified company focused on the development of precision diagnostic consumer products and
8mo agoALBTAvalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq RulesGlobeNewswireFREEHOLD, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a diversified company focused on the development of precision diagnostic consumer products and
8mo agoALBTAvalon GloboCare's Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media InfrastructureGlobeNewswireFREEHOLD, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a diversified company focused on the development of precision diagnostic consumer products and
8mo agoALBTAvalon GloboCare's Subsidiary Files Third U.S. Provisional Patent for its Catch-Up Generative AI Video PlatformGlobeNewswireFREEHOLD, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a diversified company focused on the development of precision diagnostic consumer products and
9mo agoALBTAvalon GloboCare Eliminates Majority of Debentures Through $2.6 Million Conversion, Strengthening Balance Sheet, Reduces OverhangGlobeNewswireConversion Improves Capital Structure, and Reinforces Nasdaq Compliance, Enhancing Shareholder Value Company Believes That Substantially All of the Converted Shares Have Been Sold FREEHOLD, N.J., Feb. 02, 2026 (GLOBE
9mo agoALBTAvalon GloboCare's Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video CommentaryGlobeNewswireFREEHOLD, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a diversified company focused on the development of precision diagnostic consumer products and
9mo agoALBTAvalon GloboCare Announces FDA Registration Renewal for KetoAir™ and Planned B2B and B2C Launch Through Catch-Up™, Its Automated Generative AI-Powered Short-Form Video SaaS PlatformGlobeNewswireFREEHOLD, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a diversified company focused on the development of precision diagnostic consumer products and
10mo agoALBTAvalon GloboCare Regains Compliance with Nasdaq Stockholders' Equity Requirement, Launches Marketing for Automated Generative AI Video PlatformGlobeNewswireFREEHOLD, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a diversified company focused on the development of precision diagnostic consumer products and the
10mo agoALBTAvalon GloboCare Board Director Highlights RPM Interactive's Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.comGlobeNewswireFREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of precision diagnostic consumer products, today announced that Michael Mathews, a member
10mo agoALBTE.F. Hutton Advises on RPM Interactive's Acquisition by Avalon GloboCareGlobeNewswireNEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- E.F. Hutton & Co., a leading investment bank providing strategic advisory and capital markets services, today is proud to have served as exclusive financial advisor to
11mo agoALBT MYSEMyseum Completes Sale of Minority Stake in RPM Interactive for Approximately $6.5 Million in Avalon GloboCare AcquisitionGlobeNewswireNEW BRUNSWICK, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Myseum, Inc. (NASDAQ:MYSE) ("Myseum" or the "Company") today announced the completion of the sale of its approximately 34% ownership interest in RPM Interactive,
11mo agoALBT ASPUAvalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock TransactionGlobeNewswireCompany forms a new subsidiary, Avalon Quantum AI, LLC, in connection with the acquisition Acquisition expected to resolve Nasdaq minimum stockholders' equity deficiency RPM Interactive has developed a fully automated,
11mo agoALBTAvalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International ExpansionGlobeNewswireFREEHOLD, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of precision diagnostic consumer products, today announced a series of Q3 2025
1y agoALBTAvalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United KingdomGlobeNewswireFREEHOLD, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of precision diagnostic consumer products, today announced that it will launch the sales
1y agoALBTAvalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First RespondersGlobeNewswireFREEHOLD, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of precision diagnostic consumer products, today announced that its subsidiary, Q&A
1y agoALBTAvalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong KongGlobeNewswireFREEHOLD, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of precision diagnostic consumer products, today announced the issuance of a new standard
1y agoALBTAvalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired DrivingGlobeNewswireFREEHOLD, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of precision diagnostic consumer products, today announced that it entered into a
1y agoALBTAvalon GloboCare Advances Proposed Merger with YOOV with Filing of Registration StatementGlobeNewswireFREEHOLD, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer
1y agoALBTAvalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs' Fitness Challenge with KetoAirGlobeNewswireFREEHOLD, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer
1y agoALBTAvalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in ChinaGlobeNewswireFREEHOLD, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer
1y agoALBTAvalon GloboCare Partners with Pounds Transformation Clinics to Unveil the KetoAir BrAce 4 Impact Challenge SeriesGlobeNewswireFREEHOLD, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer
1y agoALBTAvalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger AgreementGlobeNewswireYOOV Achieves 59.1% Annual Revenue Growth, Reporting Unaudited Revenue of $45.7 Million with Net Income of $3.4 Million for Calendar Year 2024, Versus Unaudited Revenue of $28.7 Million with Net Loss of $2.4 Million for
1y agoALBT BICX HTOO VMARFusion Fuel Appoints Luisa Ingargiola to Board of DirectorsGlobeNewswireDUBLIN, Feb. 27, 2025 (GLOBE NEWSWIRE) -- via IBN – Fusion Fuel Green PLC (NASDAQ:HTOO) ("Fusion Fuel" or the "Company"), a leading provider of gas and hydrogen energy solutions, today announced the
1y agoALBTAvalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in ChinaGlobeNewswireFREEHOLD, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and laboratory services, announced today that it has
1y agoALBTAvalon GloboCare Regains Compliance with Nasdaq Continued Listing RequirementsGlobeNewswireFREEHOLD, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and laboratory services, today announced that the
1y agoALBTAvalon GloboCare Launches "BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer DeviceGlobeNewswireFREEHOLD, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and laboratory services, today announced the launch of
2y agoALBTAvalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir SalesGlobeNewswireFREEHOLD, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and laboratory services, today announced that it has
2y agoALBTAvalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired DrivingGlobeNewswireFREEHOLD, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and laboratory services, today announced that it
2y agoALBTAvalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance PlanGlobeNewswireFREEHOLD, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and laboratory services, today announced that it will
2y agoALBTAvalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer DeviceGlobeNewswireFREEHOLD, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and laboratory services, today announced its
2y agoALBTAvalon's Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter DeviceGlobeNewswireFREEHOLD, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
2y agoALBTAvalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid AddictionGlobeNewswireFREEHOLD, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
2y agoALBTAvalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.usGlobeNewswireFREEHOLD, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
2y agoALBTAvalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 ConferenceGlobeNewswireFREEHOLD, N.J., June 20, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
2y agoALBTAvalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly ReportGlobeNewswireFREEHOLD, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
2y agoALBT BICX LRHCLa Rosa Appoints Corporate Finance Executive Lourdes Felix to its Board of DirectorsGlobeNewswireCelebration, FL, May 21, 2024 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) ("La Rosa" or the "Company"), a holding company for five agent-centric, technology-integrated, cloud-based, multi-service real
2y agoALBTAvalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 ConferenceGlobeNewswireFREEHOLD, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today
2y agoALBTAvalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European UnionGlobeNewswireFREEHOLD, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, is
2y agoALBTAvalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the USGlobeNewswireFREEHOLD, N.J., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today
3y agoALBTAvalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic KetoacidosisGlobeNewswireFREEHOLD, N.J., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today
3y agoALBTApple Approves Use of Avalon GloboCare's KetoAir Mobile ApplicationGlobeNewswireKetoAir™ Mobile Application Launches in Apple App Store KetoAir™ Mobile Application also Available in the Google Play Store FREEHOLD, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare
3y agoALBTAvalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter DeviceGlobeNewswireFREEHOLD, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today
3y agoALBTAvalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT)GlobeNewswireFREEHOLD, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today